Avalo Therapeutics AVTX
NASDAQ AVTX
$14.95 -0.38 (-2.48%)
At close: Oct 1, 2026 · 4:00 PM EDT

Avalo Therapeutics (AVTX) Accumulated Depreciation (2014 - 2015)

Updated

Avalo Therapeutics' Accumulated Depreciation was $60,835 in Q4 2015, up 63.0% from $37,328 a year earlier.

Analysis

Avalo Therapeutics (AVTX) Accumulated Depreciation (2014 - 2015) Analysis & Trends

  • In earlier years, Accumulated Depreciation was $37,328 in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Avalo Therapeutics 668.42 Mn 668.42 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 60,835.00
Dec 31, 2014 37,328.00
API Access

Avalo Therapeutics Accumulated Depreciation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=AVTX&period=max&api_key=YOUR_API_KEY